DeciMab

N/A

Report date: 2025/03/18 18:18:48

Base Information

Drug NameDeciMab
Drug Alias NameN2 binding inhibitors (DecImmune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSkeletal muscle myosin 2 inhibitors
TargetsSkeletal muscle myosin 2
Therapy Area/IndicationsVasculitisReperfusion InjuryCardiotoxicity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDecImmune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDecImmune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsVasculitisReperfusion InjuryCardiotoxicity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A